Most important cardiotoxicity of immune checkpoint inhibitors – Cardiology MCQ

Most important cardiotoxicity of immune checkpoint inhibitors – Cardiology MCQ Interactive Kindle Edition: Check here for more Cardiology MCQs! Immune checkpoint inhibitors are novel anti cancer drugs targeting immune checkpoint molecules: cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed cell death 1 (PD-1) and its ligand (PD-L1) [1]. They are highly useful in a large number of solid and hematological tumours. The most important recently highlighted cardiovascular adverse effect of immune checkpoint inhibitors is: Fulminant myocarditis Acute myocardial infarction QT prolongation Venous thromboembolism Post your answer as a comment below. Correct answer will be published on: Mar 25, 2018 @ 06:57 Reference Varricchi G, Galdiero MR, Marone G, Criscuolo G, Triassi M, Bonaduce D, Marone G, Tocchetti CG. Cardiotoxicity of immune checkpoint inhibitors. ESMO Open. 2017 Oct 26;2(4):e000247. The post Most important cardiotoxicity of immune checkpoint inhibitors – Cardiology MCQ appeared first on Cardiophile MD.
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs